Can a mushroom compound supercharge cancer treatment?
NCT ID NCT04513028
Summary
This study is testing whether adding an oral supplement called beta-glucan to the immunotherapy drug pembrolizumab can improve the immune system's response against melanoma. It involves 30 adults with stage III or IV melanoma who have no active disease but are receiving pembrolizumab to prevent recurrence. Researchers will measure changes in immune cells and track whether the combination leads to better cancer control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA STAGE III are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Louisville
RECRUITINGLouisville, Kentucky, 40202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.